Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2023 Diversity, Equity, & Inclusion Report
    • 2023 Industry Snapshot
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 MA Life Sciences Workforce Analysis Report
    • Economic Development
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Bioversity at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

Firalis Molecular Precision

Life Sciences | Contract Research & Manufacturing
Cambridge, MA 8572590185 Website None LinkedIn Facebook

Overview

Firalis Molecular Precision is a one-stop-shop for biomarker R&D programs. Dedicated to academic institutes and biopharmaceutical companies, our end-to-end platform for multi-omics biomarker discovery and validation to assay development and manufacturing offers a complete support from research/clinical study design to IVD kits regulatory approval.

Our value offer is based on high customizable, flexible and qualitative services to extract the best outcomes from your clinical samples in 3 main therapeutic areas: Neurology, Cardiology and Oncology.

Firalis Molecular Precision also leads proprietary programs to develop cutting-edge CE-marked long non-coding RNA-based in vitro diagnostic kits in Neurology (Neurolincs) and Cardiology (Fimics).

Company News

News

Multi-Omics Biomarkers Discovery, Validation and Clinical Testing

Feb 26, 2023

Posted by Firalis Molecular Precision

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved